Quarterly report pursuant to Section 13 or 15(d)

REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details1)

v3.22.2.2
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details1) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
General and administrative $ 1,396,989 $ 1,264,102       $ 4,373,285 $ 3,970,112    
Research and development 603,105 409,013       1,720,925 1,410,577    
Loss from operations (2,000,094) (1,673,115)       (6,094,210) (5,380,689)    
Net loss $ (2,004,339) $ (1,551,624)       $ (6,104,498) $ (5,490,845)    
Basic and diluted loss per share $ (0.21) $ (0.24)       $ (0.65) $ (0.94)    
Previously Reported [Member]                  
General and administrative   $ 1,263,490 $ 1,281,488 $ 1,436,822 $ 2,718,310   $ 3,981,801 $ 6,932,921 $ 4,820,762
Research and development   442,340 467,918 646,752 1,114,670   1,557,010 2,119,684 3,754,913
Total cost and expenses   1,705,830 1,749,406 2,083,574 3,832,980   5,538,811 9,052,605 8,575,675
Loss from operations   (1,705,830) (1,749,406) (2,083,574) (3,832,980)   (5,538,811) (9,052,605) (8,575,675)
Net loss   $ (1,584,339) $ (1,845,648) $ (2,218,978) $ (4,064,627)   $ (5,648,968) $ (9,163,366) $ (9,105,729)
Basic and diluted loss per share   $ (0.17) $ (0.28) $ (0.43) $ (0.70)   $ (0.81) $ (1.20) $ (1.79)
Adjustment [Member]                  
General and administrative   $ 612 $ 972 $ 13,272 $ 12,300   $ 11,689 $ 238,302 $ 57,086
Research and development   33,327 49,447 63,659 113,106   146,433 169,184 494,141
Total cost and expenses   (32,715) 48,475 (76,931) (125,406)   (158,122) (407,486) (551,227)
Loss from operations   32,715 48,476 76,931 125,406   158,123 407,485 551,227
Net loss   $ 32,715 $ 48,475 $ 76,931 $ 125,406   $ 158,122 $ 407,486 $ 551,227
Basic and diluted loss per share   $ (0.07) $ 0.00 $ 0.02 $ 0.03   $ (0.13) $ 0.05 $ 0.11
Revised [Member]                  
General and administrative   $ 1,264,102 $ 1,282,460 $ 1,423,550 $ 2,706,010   $ 3,970,112 $ 6,694,619 $ 4,763,676
Research and development   409,013 418,471 583,093 1,001,564   1,410,577 1,950,500 3,260,772
Total cost and expenses   1,673,115 1,700,931 2,006,643 3,707,574   5,380,689 8,645,119 8,024,448
Loss from operations   (1,673,115) (1,700,931) (2,006,643) (3,707,574)   (5,380,689) (8,645,119) (8,024,448)
Net loss   $ (1,551,624) $ (1,797,173) $ (2,142,047) $ (3,939,221)   $ (5,490,845) $ (8) $ (8,554,502)
Basic and diluted loss per share   $ (0.24) $ (0.28) $ (0.41) $ (0.67)   $ (0.94) $ (1.15) $ (1.68)